
Akums Drugs and Pharmaceuticals Limited: Endeavour to deliver Quality Medicines and Advancing Pharmaceutical Manufacturing
Established with a clear vision, Akums remains unwavering in its commitment to excel in the pharmaceutical industry.
Established with a clear vision, Akums remains unwavering in its commitment to excel in the pharmaceutical industry.
The company reported a consolidated net profit of ₹5 crore in the July to September quarter of FY24. The company had reported a loss of ₹37 crore in the same period last year.
The stellar run continues post-Covid as promoters reap benefits of growth in India and new launches in key markets.
Nine established pharma companies will be selected on the basis of their willingness to carry out research in six priority areas with academic collaboration in government research institutions.
In a letter to Mansukh Mandaviya, AIMED says the final draft of the Bill does not propose an independent regulatory regime for medical devices
The revenue from operations of the Mumbai-based company stood at ₹11,940.8 crore, up 10.9% as against 10,761.7 crore in the Q1 of FY23.
Glenmark Pharmaceutical said that the settlement will make clear that the company denies allegations by the Plaintiff groups.
As per the new arrangement, Biocon Biologics will have access to 100 million doses of vaccines annually together with the distribution rights to Serum Institute’s vaccine portfolio.
The National Pharmaceutical Pricing Authority (NPPA) said that the prices have been hiked in line with surging wholesale price inflation.
USTR’s annual Special 301 Report lists out the countries that are perceived to have serious deficiencies in their national IPR systems.